NCBiotech News

Durham-based 410 Medical, a medical device company developing new technologies for emergency and critical care, has completed its $7.5 million Series B venture capital financing.

The funding, which had an initial closing late in 2022, was led by Durham-based Hatteras Venture Partners with participation from existing investors including Orlando Health Ventures, OSF Healthcare and Raleigh-based WakeMed, and new investors Ballad Ventures and Catalyst by Wellstar.

Durham-based biotechnology startup Tavros Therapeutics has announced its second collaboration in six months to find new targets and therapies for cancer.

Syneos Health, a global contract research organization (CRO) headquartered in Morrisville, will likely be sold to a consortium of private investment firms in a deal valued at $7.1 billion.

IngateyGen, LLC, a company working to use gene-editing technology to produce low-allergy peanut varieties, recently moved from Elizabeth City to Research Triangle Park. The company is already reaping benefits from the area’s rich resources.

Biotalys, headquartered in Research Triangle Park, will collaborate with global agricultural giant Syngenta Crop Protection to develop new biological control methods that can manage pests in a broad variety of crops, the companies announced.

As a girl growing up on the coasts of Denmark and Sweden, Nikita Michelsen treasured delicious seafood dishes made in her grandmother’s kitchen.

An exciting group of startups innovating in health care pitched as part of the April 27 event, “Aligning Health Care Innovation in North Carolina: Health Systems, Payers, Innovators, and the Quintuple Aim.”

RTP-based restor3d is using 3D printing, artificial intelligence and machine learning to design patient-specific surgical implants and related instruments across multiple fields of medicine.

Scientists and others across North Carolina interested in precision and environmental health are invited to a free symposium May 8 at NCBiotech headquarters in RTP.

NuRevelation, an RTP-based company founded by a Black NC woman with a chemistry degree to produce Southern Wicked Lemonade, is now raising capital to develop a nanoparticle-based drug-delivery platform.

StrideBio, a gene therapy company based in Research Triangle Park, has sold its intellectual property to Ginkgo Bioworks of Boston.

NCBiotech will host the conference “Aligning Health Care Innovation in North Carolina: Health Systems, Payers, Innovators, and the Quintuple Aim” on April 27.

The Greenville-Pitt County Chamber of Commerce's Grow Local program gives students ideas on cool careers they might have never considered but might want to pursue, such as biomanufacturing.

Sciencix, a Cary supplier of replacement parts for instrumentation used in biotech and pharma manufacturing, is being honored by the U.S. Small Business Administration as its 2023 Small Business Exporter of the Year.

Texas-based TFF Pharmaceuticals is leaning on its North Carolina development team to advance a novel drug-delivery technology that could make medicines safer and more effective.